The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Huang, Yi Fan ^a   Cheng, Qian ^a   Jiang, Chun Miao ^a   An, Shu ^a   Xiao, Lan ^a   Gou, Yong Chao ^a   Yu, Wen Jing ^a   Lei, Lei ^a   Chen, Qian Ming ^a   Wang, Yating ^a   Wang, Jun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; BELIMUMAB; IMMUNOGLOBULIN FC FRAGMENT; MUSCARINIC RECEPTOR BLOCKING AGENT; AUTOANTIBODY;

ARTICLE; B LYMPHOCYTE; DISEASE COURSE; GENETIC PREDISPOSITION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SJOEGREN SYNDROME; TH1 CELL; TH17 CELL; TH2 CELL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SJOGREN'S SYNDROME; T LYMPHOCYTE SUBPOPULATION; REVIEW;

AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; HUMANS; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 84880900850     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/160491     Document Type: Article

References (37)

1. Tabbara K. F., Vera-Cristo C. L., Sjogren syndrome. Current Opinion in Ophthalmology 2000 11 6 449 454 2-s2.0-0033625958 10.1097/00055735-200012000- 00011
2. Vasudevan A., Bhide P. G., Angiogenesis in the embryonic CNS: a new twist on an old tale. Cell Adhesion & Migration 2008 2 3 167 169 2-s2.0-65349095543
3. Tzioufas A. G., Tatouli I. P., Moutsopoulos H. M., Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms. La Presse Médicale 2012 41 9, part 2 e451 e460 10.1016/j.lpm.2012.05.022
4. Routsias J. G., Tzioufas A. G., Sjögren's syndrome-study of autoantigens and autoantibodies. Clinical Reviews in Allergy and Immunology 2007 32 3 238 251 2-s2.0-36949009855 10.1007/s12016-007-8003-8
5. Elkon K. B., Gharavi A. E., Hughes G. R. V., Moutsoupoulos H. M., Autoantibodies in the sicca syndrome. Annals of the Rheumatic Diseases 1984 43 2 243 245 2-s2.0-0021326779
6. Tengner P., Halse A.-K., Haga H.-J., Jonsson R., Wahren-Herlenius M., Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cels in salivary glands from patients with Sjögren's syndrome. Arthritis & Rheumatism 1998 41 12 2238 2248
7. Hammi A. R., Al-Hashimi I. H., Nunn M. E., Zipp M., Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome. Journal of Oral Pathology & Medicine 2005 34 4 198 203 2-s2.0-15944407208 10.1111/j.1600-0714.2004.00301.x
8. Davidson B. K. S., Kelly C. A., Griffiths I. D., Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology 1999 38 3 245 253 2-s2.0-0033087683 10.1093/rheumatology/38.3.245
9. Fauchais A. L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M. O., Hachulla E., Vidal E., Hatron P. Y., Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmunity Reviews 2010 9 9 595 599 2-s2.0-77954385282 10.1016/j.autrev.2010.05.004
10. Selmi C., Luigi Meroni P., Eric Gershwin M., Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis. Journal of Autoimmunity 2012 39 1-2 34 42 2-s2.0-83355170729 10.1016/j.jaut.2011.11.005
11. 2and cyclic AMP. European Journal of Oral Sciences 2010 118 2 131 138 2-s2.0-77951655095 10.1111/j.1600-0722.2010.00716.x
12. Smith P. M., Dawson L. J., Autoantibodies and Sjögren's syndrome: a physiologist's perspective. Current Pharmaceutical Biotechnology 2012 13 10 2063 2070 10.2174/138920112802273218
13. Tsuboi H., Nakamura Y., Iizuka M., Matsuo N., Matsumoto I., Sumida T., Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor. Modern Rheumatology 2012 22 2 264 271 2-s2.0-80052030325 10.1007/s10165-011-0514-8
14. Singh N., Cohen P. L., The T cell in Sjögren's syndrome: force majeure, not spectateur. Journal of Autoimmunity 2012 39 3 229 233 10.1016/j.jaut.2012.05.019
15. Crane I. J., Forrester J. V., Th1 and Th2 lymphocytes in autoimmune disease. Critical Reviews in Immunology 2005 25 2 75 102 2-s2.0-21344467014 10.1615/CritRevImmunol.v25.i2.10
16. Fox R. I., Kang H.-I., Pathogenesis of Sjögren's syndrome. Rheumatic Disease Clinics of North America 1992 18 3 517 538 2-s2.0-0026610715
17. Bertorello R., Cordone M. P., Contini P., Rossi P., Indiveri F., Puppo F., Cordone G., Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity. Clinical and Experimental Medicine 2004 4 3 148 151 2-s2.0-11944249878 10.1007/s10238-004-0049-9
18. Mitsias D. I., Tzioufas A. G., Veiopoulou C., Zintzaras E., Tassios I. K., Kogopoulou O., Moutsopoulos H. M., Thyphronitis G., The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clinical & Experimental Immunology 2002 128 3 562 568 2-s2.0-0036281216 10.1046/j.1365-2249.2002.01869.x
19. Sakai A., Sugawara Y., Kuroishi T., Sasano T., Sugawara S., Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. The Journal of Immunology 2008 181 4 2898 2906 2-s2.0-53149131365
20. Nguyen C. Q., Hu M. H., Li Y., Stewart C., Peck A. B., Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis & Rheumatism 2008 58 3 734 743 2-s2.0-40549091625 10.1002/art.23214
21. Cornec D., Devauchelle-Pensec V., Tobon G. J., Pers J. O., Jousse-Joulin S., Saraux A., B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment. Journal of Autoimmunity 2012 39 3 161 167 10.1016/j.jaut.2012.05.014
22. + T cells. The Journal of Immunology 2007 178 8 4793 4802 2-s2.0-34247110499
23. Hansen A., Daridon C., Dörner T., What do we know about memory B cells in primary Sjögren's syndrome? Autoimmunity Reviews 2010 9 9 600 603 2-s2.0-77954387569 10.1016/j.autrev.2010.05.005
24. Aqrawi L. A., Skarstein K., Bredholt G., Brun J. G., Brokstad K. A., Autoantigen-specific memory B cells in primary Sjögren's syndrome. Scandinavian Journal of Immunology 2012 75 1 61 68 2-s2.0-83455224582 10.1111/j.1365-3083.2011.02625.x
25. Pascual V., Liu Y. J., Magalski A., de Bouteiller O., Banchereau J., Capra J. D., Analysis of somatic mutation in five B cell subsets of human tonsil. Journal of Experimental Medicine 1994 180 1 329 339 2-s2.0-0028227203 10.1084/jem.180.1.329
26. Varin M. M., Guerrier T., Devauchelle-Pensec V., Jamin C., Youinou P., Pers J. O., In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmunity Reviews 2012 11 4 252 258 2-s2.0-84857060945 10.1016/j.autrev.2011. 10.005
27. Daridon C., Devauchelle V., Hutin P., Le Berre R., Martins-Carvalho C., Bendaoud B., Dueymes M., Saraux A., Youinou P., Pers J.-O., Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis & Rheumatism 2007 56 4 1134 1144 2-s2.0-34247230559 10.1002/art.22458
28. Groom J., Kalled S. L., Cutler A. H., Olson C., Woodcock S. A., Schneider P., Tschopp J., Cachero T. G., Batten M., Wheway J., Mauri D., Cavill D., Gordon T. P., Mackay C. R., Mackay F., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. The Journal of Clinical Investigation 2002 109 1 59 68 2-s2.0-0036144353 10.1172/JCI200214121
29. Abdulahad W. H., Kroese F. G. M., Vissink A., Bootsma H., Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome. Journal of Autoimmunity 2012 39 1-2 103 111 2-s2.0-84856790672 10.1016/j.jaut.2012.01.009
30. Meijer J. M., Meiners P. M., Vissink A., Spijkervet F. K. L., Abdulahad W., Kamminga N., Brouwer E., Kallenberg C. G. M., Bootsma H., Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism 2010 62 4 960 968 2-s2.0-77950538947 10.1002/art.27314
31. Meiners P. M., Vissink A., Kallenberg C. G., Kroese F. G., Bootsma H., Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point? Expert Opinion on Biological Therapy 2011 11 10 1381 1394 2-s2.0-80052463563 10.1517/14712598.2011.605352
32. Pers J. O., Devauchelle V., Daridon C., Bendaoud B., Le Berre R., Bordron A., Hutin P., Renaudineau Y., Dueymes M., Loisel S., Berthou C., Saraux A., Youinou P., BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis & Rheumatism 2007 56 5 1464 1477 2-s2.0-34248597383 10.1002/art.22603
33. Harley J. B., Scofield R. H., Reichlin M., Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus. Rheumatic Disease Clinics of North America 1992 18 2 337 358 2-s2.0-0026610438
34. Tzioufas A. G., Kapsogeorgou E. K., Moutsopoulos H. M., Pathogenesis of Sjögren's syndrome: what we know and what we should learn. Journal of Autoimmunity 2012 39 1-2 4 8 2-s2.0-84856623290 10.1016/j.jaut.2012.01.002
35. Tzioufas A. G., Wassmuth R., Dafni U. G., Guialis A., Haga H.-J., Isenberg D. A., Jonsson R., Kalden J. R., Kiener H., Sakarellos C., Smolen J. S., Sutcliffe N., Vitali C., Yiannaki E., Moutsopoulos H. M., Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study. Annals of the Rheumatic Diseases 2002 61 5 398 404 2-s2.0-0036253051 10.1136/ard.61.5.398
36. Lisi S., Sisto M., Lofrumento D. D., Altered I B α expression promotes NF- B activation in monocytes from primary Sjögren's syndrome patients. Pathology 2012 44 6 557 561
37. Cay H. F., Sezer I., Dogan S., Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome. Clinical and Experimental Rheumatology 2012 30 6 843 849